Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Edetic acid
Drug ID BADD_D00745
Description A chelating agent (chelating agents) that sequesters a variety of polyvalent cations. It is used in pharmaceutical manufacturing and as a food additive.
Indications and Usage For the reduction of blood levels and depot stores of lead in lead poisoning (acute and chronic) and lead encephalopathy, in both pediatric populations and adults.
Marketing Status approved; vet_approved
ATC Code V03AB03
DrugBank ID DB00974
KEGG ID D00052
MeSH ID D004492
PubChem ID 6049
TTD Drug ID D00KEP
NDC Product Code Not Available
UNII 9G34HU7RV0
Synonyms Edetic Acid | Acid, Edetic | EDTA | Ethylenedinitrilotetraacetic Acid | Acid, Ethylenedinitrilotetraacetic | N,N'-1,2-Ethanediylbis(N-(carboxymethyl)glycine) | Edathamil | Ethylenediaminetetraacetic Acid | Acid, Ethylenediaminetetraacetic | Versene | Chelaton 3 | Copper EDTA | EDTA, Copper | Coprin | Dicobalt EDTA | EDTA, Dicobalt | Disodium Calcitetracemate | Calcitetracemate, Disodium | Distannous EDTA | EDTA, Distannous | Edetate Disodium Calcium | Calcium Disodium Edetate | Edetate, Calcium Disodium | Edetates | Edetic Acid, Calcium Salt | Edetic Acid, Calcium, Sodium Salt | Edetic Acid, Chromium Salt | Chromium EDTA | EDTA, Chromium | Edetic Acid, Dipotassium Salt | Edetic Acid, Disodium Salt | Disodium Ethylene Dinitrilotetraacetate | Dinitrilotetraacetate, Disodium Ethylene | Ethylene Dinitrilotetraacetate, Disodium | Disodium EDTA | EDTA, Disodium | Edetic Acid, Disodium Salt, Dihydrate | Edetic Acid, Disodium, Monopotassium Salt | Edetic Acid, Magnesium Salt | Edetic Acid, Monopotassium Salt | Edetic Acid, Monosodium Salt | Edetic Acid, Potassium Salt | Potassium EDTA | EDTA, Potassium | Edetic Acid, Sodium Salt | Gallium EDTA | EDTA, Gallium | Magnesium Disodium EDTA | EDTA, Magnesium Disodium | Edetic Acid, Disodium, Magnesium Salt | Stannous EDTA | EDTA, Stannous | Tetracemate | Ethylene Dinitrilotetraacetate | Dinitrilotetraacetate, Ethylene | Versenate | Calcium Disodium Versenate | Disodium Versenate, Calcium | Versenate, Calcium Disodium | Calcium Tetacine | Tetacine, Calcium
Chemical Information
Molecular Formula C10H16N2O8
CAS Registry Number 60-00-4
SMILES C(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Anaemia01.03.02.001--
Arthralgia15.01.02.001--
Aspartate aminotransferase increased13.03.04.011--
Asthenia08.01.01.001--Not Available
Blood uric acid increased13.02.04.001--Not Available
Blood zinc decreased13.11.01.036--Not Available
Body temperature increased13.15.01.001--Not Available
Cheilosis07.05.01.002; 23.03.03.026--Not Available
Chills15.05.03.016; 08.01.09.001--
Dermatitis23.03.04.002--Not Available
Dermatitis exfoliative23.03.07.001; 10.01.01.004--
Diarrhoea07.02.01.001--
Discomfort08.01.08.003--Not Available
Fatigue08.01.01.002--
Feeling abnormal08.01.09.014--Not Available
Gastrointestinal disorder07.11.01.001--Not Available
Glycosuria20.02.01.005--
Haematuria24.07.01.047; 20.02.01.006; 21.10.01.018--
Headache17.14.01.001--
Hyperuricaemia14.09.01.003--
Hypoaesthesia23.03.03.081; 17.02.06.023--Not Available
Hypotension24.06.03.002--
Lacrimation increased06.08.02.004--
Malaise08.01.01.003--
Myalgia15.05.02.001--
Nasal congestion22.04.04.001--
Nausea07.01.07.001--
Necrosis24.04.02.006; 08.03.03.001--Not Available
Nephropathy toxic20.05.03.002; 12.03.01.010--Not Available
Nephrotic syndrome20.05.01.002--
The 1th Page    1 2    Next   Last    Total 2 Pages